The Limited Times

Now you can see non-English news...

Dr. Huerta explains how bamlanivimab works, the first drug designed against covid-19 | Video | CNN

2020-11-17T11:18:19.312Z


Bamlanivimab, a drug based on monoclonal antibodies for the treatment of non-hospitalized cases of patients with covid-19, was approved by | Latin America | CNN


Bamlanivimab, a monoclonal antibody-based drug for the treatment of out-of-hospital cases of COVID-19 patients, has been approved by the US Food and Drug Administration (FDA).

The treatment works by attacking the virus and prevents the patient from getting worse.

Dr. Huerta explains in more detail.

Source: cnnespanol

All news articles on 2020-11-17

Similar news:

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.